SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
OnKure Therapeutics, Inc.
@OKUR_InsiderForm 4 Filing: Leverone Jason A. Sells $1,332.079 of $OKUR
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
OnKure Therapeutics, Inc.
Ticker: $OKUR
Transaction Value
$1,332.079
Price/Share: $4.40
transaction date
2026-06-22
Shares: 303
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Leverone Jason A., holds the title of Chief Financial Officer at OnKure Therapeutics, Inc..
On 2026-06-22, the insider transacted 303 shares.The shares were transacted at a weighted average price of $4.40 per share, resulting in a total market-relevant value of $1,332.079.
Executive Summary Summary
Leverone Jason A. (Chief Financial Officer) sold $1K of $OKUR
Post-Transaction Position: 18,802 shares
SEC Accession No: 0001692747-26-000003 (CIK: 1692747)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.